JOCK PERKINS: Open Payments
NPI 1306248778 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 37 payments from 13 companies in 2025. Trend: 2023 $704 · 2024 $259 · 2025 $893
Food & beverage: $793Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $191 |
| Regeneron Healthcare Solutions, Inc. | 3 | $157 |
| Galderma Laboratories, L.P. | 3 | $94 |
| ABBVIE INC. | 4 | $92 |
| UCB, Inc. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| LEO Pharma Inc. | 2 | $46 |
| Incyte Corporation | 2 | $37 |
| SpringWorks Therapeutics, Inc. | 1 | $33 |
| MIMEDX Group, Inc. | 2 | $32 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI, Bimzelx, OPZELURA, GOMEKLI, bio-ConneKt.
Industry payments across ID — which companies pay providers there.
